Sign Up For Free
Speaking at Digestive Disease Week in Washington, two doctors, one from Toronto’s Mount Sinai hospital, and the other from Meir General hospital in Israel, gave separate presentations on cannabis treatments for inflammatory bowel disease (IBD) and ulcerative colitis (UC).

Mark Silverber, MD, PhD, of Mount Sinai led a review on cannabis and IBD, stating that cannabis is “not unreasonable” to try after exhausting other treatments. He continued to state "It is not clear if cannabis can be used to induce remission in IBD. Further research is warranted to determine if cannabis can be used as an adjunctive therapy to treat symptoms such as nausea, pain, and anorexia," and to examine the long-term effects.”

He also cited reasons such as the fact that current therapies are effective, but require immune suppression and are often accompanied by adverse events, and there is significant morbidity in young patients with systemic and local symptoms. 

In addition, Timna Naftali, MD, of Meir General Hospital presented preliminary results of a randomized trial that showcased consuming cannabis for eight weeks helped ulcerative colitis (UC) patients. 

Source: https://www.medpagetoday.com/meetingcoverage/ddw/73265

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.


Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.